New Delhi, Aug 23 (PTI) Unichem Laboratories Ltd on Tuesday said it has received approval from the US health regulator to market its generic carbamazepine tablets, indicated as an anticonvulsant drug.

The approval granted by the US Food and Drug Administration (USFDA) is for the abbreviated new drug application (ANDA) of Carbamazepine Tablets of strength 200 mg, Unichem said in a regulatory filing.

Also Read | Mumbai Traffic Update: British-Era Carnac Flyover Closed for Reconstruction, Know Alternative Routes Here.

It is the generic version of Tegretol (Carbamazepine) tablet, 200 mg of Novartis Pharmaceuticals Corp.

The drug will be commercialised from the company's Goa plant, it added.

Also Read | Income Tax Returns: ITR Refund Rejected? Here's How to Raise a Refund Re-Issue Request.

Carbamazepine tablets are indicated for use as an anticonvulsant drug and in the treatment of the pain associated with true trigeminal neuralgia, a condition that causes painful sensations on one side of the face.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)